79
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Messenger RNA Levels and Binding Sites of Muscarinic Acetylcholine Receptors in Gastrointestinal Muscle Layers from Healthy Dairy Cows

, , , &
Pages 147-166 | Published online: 10 Oct 2008
 

Abstract

Acetylcholine interacts with muscarinic receptors (M) to mediate gastrointestinal (GI) smooth muscle contractions. We have compared mRNA levels and binding sites of M1to M5 in muscle tissues from fundus abomasi, pylorus, ileum, cecum, proximal loop of the ascending colon (PLAC), and external loop of the spiral colon (ELSC) of healthy dairy cows. The mRNA levels were measured by quantitative RT-PCR. The inhibition of [3H]-QNB (1-quinuclidinyl-[phenyl-4-3H]-benzilate) binding by M antagonists [atropine (M1 − 5), pirenzepine (M1), methoctramine (M2), 4-DAMP (M3), and tropicamide (M4)] was used to identify receptors at the functional level. Maximal binding (Bmax) was determined through saturation binding with atropine as a competitor. The mRNA levels of M1, M2, M3, and M5 represented 0.2, 48, 50, and 1.8%, respectively, of the total M population, whereas mRNA of M4 was undetectable. The mRNA levels of M2 and of M3 in the ileum were lower (P < 0.05) than in other GI locations, which were similar among each other. Atropine, pirenzepine, methoctramine, and 4-DAMP inhibited [3H]-QNB binding according to an either low- or high-affinity receptor pattern, whereas tropicamide had no effect on [3H]-QNB binding. The [3H]-QNB binding was dose-dependent and saturable. Bmax in fundus, pylorus, and PLAC was lower (P < 0.05) than in the ELSC, and in the pylorus lower (P < 0.05) than in the ileum. Bmax and mRNA levels were negatively correlated (r = -0.3; P < 0.05). In conclusion, densities of M are different among GI locations, suggesting variable importance of M for digestive functions along the GI tract.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.